CLYDE WORLEY: Open Payments
NPI 1942206776 · JEFFERSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 39 payments from 15 companies in 2025. Trend: 2023 $699 · 2024 $817 · 2025 $826
Food & beverage: $779Education: $47
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $175 |
| GlaxoSmithKline, LLC. | 9 | $148 |
| HEARTFLOW, INC. | 3 | $112 |
| PFIZER INC. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $47 |
| Lilly USA, LLC | 2 | $36 |
| Astellas Pharma US Inc | 1 | $29 |
| Medtronic, Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $25 |
Products named: TRELEGY ELLIPTA, FFRct, Ozempic, ELIQUIS, Rybelsus, CAPLYTA, JARDIANCE, Veozah.
Industry payments across TN — which companies pay providers there.
